223 related articles for article (PubMed ID: 21876069)
1. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms).
Mulatero P; Tizzani D; Viola A; Bertello C; Monticone S; Mengozzi G; Schiavone D; Williams TA; Einaudi S; La Grotta A; Rabbia F; Veglio F
Hypertension; 2011 Nov; 58(5):797-803. PubMed ID: 21876069
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of familial hyperaldosteronism in apparently sporadic primary aldosteronism in Germany: a single center experience.
Pallauf A; Schirpenbach C; Zwermann O; Fischer E; Morak M; Holinski-Feder E; Hofbauer L; Beuschlein F; Reincke M
Horm Metab Res; 2012 Mar; 44(3):215-20. PubMed ID: 22274719
[TBL] [Abstract][Full Text] [Related]
3. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
Zennaro MC; Jeunemaitre X
Ann Endocrinol (Paris); 2016 Jul; 77(3):214-9. PubMed ID: 27315758
[TBL] [Abstract][Full Text] [Related]
4. Primary aldosteronism: learning from the study of familial varieties.
Stowasser M; Gordon RD
J Hypertens; 2000 Sep; 18(9):1165-76. PubMed ID: 10994747
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
[TBL] [Abstract][Full Text] [Related]
6. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene.
Torpy DJ; Gordon RD; Lin JP; Huggard PR; Taymans SE; Stowasser M; Chrousos GP; Stratakis CA
J Clin Endocrinol Metab; 1998 Sep; 83(9):3214-8. PubMed ID: 9745430
[TBL] [Abstract][Full Text] [Related]
7. A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.
Carvajal CA; Campino C; Martinez-Aguayo A; Tichauer JE; Bancalari R; Valdivia C; Trejo P; Aglony M; Baudrand R; Lagos CF; Mellado C; Garcia H; Fardella CE
Hypertension; 2012 Jan; 59(1):85-91. PubMed ID: 22083159
[TBL] [Abstract][Full Text] [Related]
8. Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification.
Perez-Rivas LG; Williams TA; Reincke M
Exp Clin Endocrinol Diabetes; 2019 Feb; 127(2-03):93-99. PubMed ID: 30199917
[TBL] [Abstract][Full Text] [Related]
9. Familial hyperaldosteronism.
Stowasser M; Gordon RD
J Steroid Biochem Mol Biol; 2001 Sep; 78(3):215-29. PubMed ID: 11595502
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.
Sukor N; Mulatero P; Gordon RD; So A; Duffy D; Bertello C; Kelemen L; Jeske Y; Veglio F; Stowasser M
J Hypertens; 2008 Aug; 26(8):1577-82. PubMed ID: 18622235
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.
Monticone S; Burrello J; Tizzani D; Bertello C; Viola A; Buffolo F; Gabetti L; Mengozzi G; Williams TA; Rabbia F; Veglio F; Mulatero P
J Am Coll Cardiol; 2017 Apr; 69(14):1811-1820. PubMed ID: 28385310
[TBL] [Abstract][Full Text] [Related]
12. Recent Developments in Primary Aldosteronism.
Asbach E; Williams TA; Reincke M
Exp Clin Endocrinol Diabetes; 2016 Jun; 124(6):335-41. PubMed ID: 27219889
[TBL] [Abstract][Full Text] [Related]
13. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
14. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.
Araujo-Castro M; Parra P; Martín Rojas-Marcos P; Paja Fano M; González Boillos M; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; García Centeno R; Rebollo Román Á; Gracia Gimeno P; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Furio Collao SA; Meneses D; Sampedro Nuñez M; Escudero Quesada V; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Moya Mateo EM; Hanzu FA
Front Endocrinol (Lausanne); 2024; 15():1336306. PubMed ID: 38495792
[TBL] [Abstract][Full Text] [Related]
15. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
[TBL] [Abstract][Full Text] [Related]
16. Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism.
Stowasser M; Gordon RD; Tunny TJ; Klemm SA; Finn WL; Krek AL
Clin Exp Pharmacol Physiol; 1992 May; 19(5):319-22. PubMed ID: 1521363
[TBL] [Abstract][Full Text] [Related]
17. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.
Jeske YW; So A; Kelemen L; Sukor N; Willys C; Bulmer B; Gordon RD; Duffy D; Stowasser M
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):380-5. PubMed ID: 18307725
[TBL] [Abstract][Full Text] [Related]
18. Primary aldosteronism: who should be screened?
Monticone S; Viola A; Tizzani D; Crudo V; Burrello J; Galmozzi M; Veglio F; Mulatero P
Horm Metab Res; 2012 Mar; 44(3):163-9. PubMed ID: 22120135
[TBL] [Abstract][Full Text] [Related]
19. Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Mussa A; Camilla R; Monticone S; Porta F; Tessaris D; Verna F; Mulatero P; Einaudi S
Endocr J; 2012; 59(6):497-502. PubMed ID: 22447138
[TBL] [Abstract][Full Text] [Related]
20. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).
Lafferty AR; Torpy DJ; Stowasser M; Taymans SE; Lin JP; Huggard P; Gordon RD; Stratakis CA
J Med Genet; 2000 Nov; 37(11):831-5. PubMed ID: 11073536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
